322 related articles for article (PubMed ID: 9865309)
1. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
2. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
[No Abstract] [Full Text] [Related]
3. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients.
Figueras J; Bernardos A; Prieto M; Gómez M; Rimola A; Ortiz de Urbina J; Cuervas-Mons V; de la Mata M; Dominguez-Granados R
Transplant Proc; 2002 Aug; 34(5):1511-3. PubMed ID: 12176461
[No Abstract] [Full Text] [Related]
4. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Vanrenterghem Y; Squifflet JP; Forsythe J; Heeman U; Bäckman L; Taube D; Morales JM; Ekberg H; van Hooff J; Zanker B; Dietl KH; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
Transplant Proc; 1998 Jun; 30(4):1290-1. PubMed ID: 9636523
[No Abstract] [Full Text] [Related]
5. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
Forsythe J
Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
[No Abstract] [Full Text] [Related]
6. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
Ringe B; Braun F; Lorf T; Canelo R; Schütz E; Sattler B; Ramadori G
Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
[No Abstract] [Full Text] [Related]
8. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
9. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
[No Abstract] [Full Text] [Related]
10. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
[No Abstract] [Full Text] [Related]
11. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group.
Stratta RJ
Transplant Proc; 1997; 29(1-2):654-5. PubMed ID: 9123463
[No Abstract] [Full Text] [Related]
12. Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
Undre NA; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales JM; Andrés A; Schäfer A; Stevenson P
Transplant Proc; 1998 Jun; 30(4):1299-302. PubMed ID: 9636527
[No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
[No Abstract] [Full Text] [Related]
15. Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results.
van Hooff JP; Squifflet JP; Vanrenterghem Y
Transplant Proc; 2002 Aug; 34(5):1591-3. PubMed ID: 12176498
[No Abstract] [Full Text] [Related]
16. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
[No Abstract] [Full Text] [Related]
17. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
[No Abstract] [Full Text] [Related]
18. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
Ringe B; Braun F; Schütz E; Füzesi L; Lorf T; Canelo R; Oellerich M; Ramadori G
Transplantation; 2001 Feb; 71(4):508-15. PubMed ID: 11258429
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
Schütz E; Shipkova M; Armstrong VW; Niedmann PD; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M
Transplant Proc; 1998 Jun; 30(4):1185-7. PubMed ID: 9636479
[No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation.
Glanemann M; Klupp J; Langrehr JM; Platz KP; Schröer G; Raakow R; Stange B; Settmacher U; Bechstein WO; Neuhaus P
Transplant Proc; 2001; 33(1-2):1069-70. PubMed ID: 11267194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
